Back to Search Start Over

A peptide fraction from hardened common beans ( Phaseolus vulgaris ) induces endothelium-dependent antihypertensive and renal effects in rats.

Authors :
Ribeiro JVV
Graziani D
Carvalho JHM
Mendonça MM
Naves LM
Oliveira HF
Campos HM
Fioravanti MCS
Pacheco LF
Ferreira PM
Pedrino GR
Ghedini PC
Fernandes KF
Batista KA
Xavier CH
Source :
Current research in food science [Curr Res Food Sci] 2022 Dec 05; Vol. 6, pp. 100410. Date of Electronic Publication: 2022 Dec 05 (Print Publication: 2023).
Publication Year :
2022

Abstract

Beans reached the research spotlight as a source of bioactive compounds capable of modulating different functions. Recently, we reported antioxidant and oxidonitrergic effect of a low molecular weight peptide fraction (<3 kDa) from hardened bean ( Phaseolus vulgaris ) in vitro and ex vivo , which necessitate further in vivo assessments. This work aimed to evaluate the hypotensive effect and the involved physiological mechanisms of the hardened common bean peptide (Phaseolus vulgaris ) in normotensive (Wistar) and hypertensive (SHR) animals. Bean flour was combined with a solution containing acetonitrile, water and formic acid (25: 24: 1). Protein extract (PV3) was fractioned (3 kDa membrane). We assessed PV3 effects on renal function and hemodynamics of wistar (WT-normotensive) and spontaneously hypertensive rats (SHR) and measured systemic arterial pressure and flow in aortic and renal beds. The potential endothelial and oxidonitrergic involvements were tested in isolated renal artery rings. As results, we found that PV3: I) decreased food consumption in SHR, increased water intake and urinary volume in WT, increased glomerular filtration rate in WT and SHR, caused natriuresis in SHR; II) caused NO- and endothelium-dependent vasorelaxation in renal artery rings; III) reduced arterial pressure and resistance in aortic and renal vascular beds; IV) caused antihypertensive effects in a dose-dependent manner. Current findings support PV3 as a source of bioactive peptides and raise the potential of composing nutraceutical formulations to treat renal and cardiovascular diseases.<br />Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.<br /> (© 2022 The Authors.)

Details

Language :
English
ISSN :
2665-9271
Volume :
6
Database :
MEDLINE
Journal :
Current research in food science
Publication Type :
Academic Journal
Accession number :
36545514
Full Text :
https://doi.org/10.1016/j.crfs.2022.100410